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ABSTRACT 
Introduction: The 340B is a federal program that provides eligible rural hospitals, providers, and clinics the 
capability to purchase medications at reduced prices for outpatient use. Enrollment in the 340B program requires 
drug manufacturers to supply covered healthcare entities and eligible healthcare organizations medications at 
substantially reduced prices and has allowed covered entities to extend federal resources by offering more 
comprehensive services and reaching more of the vulnerable populations. The purpose of this research study was to 
examine utilization of 340B program within provider based clinics of a university medical school affiliated with a 
rural hospital to assess the benefits and barriers of its utilization. 
Methodology: The methodology for this study was a literature review complemented with a semi-structured interview 
of an expert in 340B program. Seven electronic databases were utilized with a total of 21 sources articles referenced 
for this review. 
Results: The type and volume of care provided in rural areas has been expanded as a result of the 340B program 
leading to median savings of $10,000 per month in prescription purchases. Pharmacy savings have ranged from $600 
to $158,000 per month depending upon whether chemotherapy was available on an outpatient basis or not. In 2010, 
total cost of drug discounts equaled $6 billion dollars, and has been is projected to be $12 billion by 2016 with typical 
a discount range between being 30% to 50%. 
Discussion/Conclusion: The results of this study suggest that the The benefits in the types and volume of services 
provided outweigh the barriers of maintaining separate drug inventories and difficulties in the management of the 
outpatient pharmacy that include audits at the state and federal levels as well as audits from pharmaceutical 
manufacturers. 
INTRODUCTION 
ackground 
The 340B is a federal program that provides eligible rural hospitals, providers, and clinics the capability to 
purchase medications at reduced prices for outpatient use. Hospitals are defined as rural if the hospital has less than 
500 beds and the population is less than 50,000 (INSERT REFERENCE). Cabell Huntington Hospital (CHH) is 
eligible for participation in the 340B program because it is a rural, disproportionate share hospital.  Disproportionate 
share hospitals serve a significantly disproportionate number of low income patients (HRSA, 2014). This program 
was created in 1992 and has permitted to a group of hospitals which cared for vulnerable populations to acquire 
prescriptions for their patients at reduced prices. Furthermore, without health insurance that provides prescription drug 
coverage, patients have been twice as likely to reduce consumption by cutting pills, skipping doses or not filling 
prescriptions entirely due to cost (Kaiser Permanente, 2008). Enrollment in the 340B program requires drug 
manufacturers to supply covered healthcare entities and eligible healthcare organizations medications at substantially 
reduced prices. It also and has allowed covered entities to extend federal resources by offering more comprehensive 
services and reaching more of the vulnerable populations (Keough & Webster, 2009). Healthcare centers were 
originally established over 40 years ago to provide primary and preventive care and have endured due to their record 
of quality and community effectiveness (Lefkowitz, 2005). Two distinctly different  cultural and geographical regions, 
rural Mississippi and inner city Boston, have provided evidence that community health centers have reduced 
disparities in healthcare provided to minorities and the most economically disadvantaged  (Geiger , 2005). Regardless 
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of the patients’ insurance status, healthcare centers have provided quality care to vulnerable populations by eliminating 
barriers to access of care and have improved health outcomes. Also no incentives have existed for physicians to 
provide care for low income patients lacking insurance within the current United States (U.S.) healthcare system 
(Wilensky & Roby, 2005). The expansion of managed care health insurance and federal programs such as 340B has 
led to hospital-physician financial collaboration creating large integrated healthcare organizations (Cuellar & Gertler, 
2006). Due to policies passed, including the Patient Protection and Affordable Care Act  (PPACA) of  2010, a variety 
of healthcare entities such as cancer centers and community hospitals can purchase medications under 340B federal 
program, irrespective of their patients’ insurance coverage or lack thereof (HRSA, 2014). In addition, hospital 
participation has increased from 591 hospitals in 2005 to include approximately one third of all U.S. hospitals or 1673 
hospitals in 2011 (Mitka, 2012a).  
The implementation of the 340B program in a rural hospital has been driven by market factors leading to 
expensive medication pricing and the need to provide affordable prescriptions costs to patients discharged from the 
hospital and patients seen in the hospital’s provider based outpatient clinics. Hospitals have maintained profit margins 
of 7.2% in 2010 because of their business acumen implements ways to procure cost savings on outpatient medications 
with programs such as 340B, but it has been increasingly faced with barriers of strict government requirements and 
Medicare provider based rules which develop difficulties in cost saving strategies (Selvam, 2012).  With hospital 
expenditures estimated to increase at a yearly rate of 4.8%  the next 5 years, hospital personnel have been faced with 
the challenge to decrease costs while maintaining patient quality and care (Shactman, Altman, Eilat, Thorpe, & 
Doonan, 2003).  Rates charged by hospitals are governed by negotiation in the private sector and by federal law when 
Medicare is the primary insurance (Hart & Siegel, 2012). 
Costs and Savings of Program 340B 
The cost of implementation of 340B program has been justified based upon annual cost savings of $330,000 
achieved with an annual outpatient prescription budget of $1 million (Endo, 2010).  The parent hospital registered for 
participation has assumed responsibility for compliance to all federal guidelines and regulations for the outpatient 
clinics and departments on site within the hospital walls. As a result, the clinics and departments must meet 
requirements set forth by Joint Commission on Accreditation of Healthcare Organizations, including limited access 
to medications and proper temperature monitoring to ensure safety and integrity (Federal Registry, 2012). Since the 
340B program does not require covered entities to provide discounted medications to indigent patients only, patients 
with excellent prescription coverage are eligible to use the service too. In addition, eligible patients have been defined 
as those who receive treatment at the parent hospital or outpatient clinics, with the exception of patients covered by 
Medicaid. Hospitals and outpatient clinics are not required to the pass the savings on medications to individual patients 
or their insurance carrier. Private pay and insurance billing are based upon Average Wholesale Price or list price 
instead of 340B government mandated purchase price. Simply stated, the 340B program has reduced the acquisition 
costs of medications but not the reimbursement (Apexus, 2014). As reported in The New York Times in 2013, it is 
feasible for an oncologist to generate $1 million in profit by treating his insured patients with medications obtained 
legally under 340B program (Pollack, 2013). 
The purpose of this research was to examine utilization of 340B program within provider based clinics of a 
university medical school, Joan C. Edwards School of Medicine (JCESOM) in Huntington, West Virginia affiliated 
with a rural hospital, Cabell Huntington Hospital (CHH), to assess the benefits and barriers of its utilization. 
METHODOLOGY 
The primary hypothesis was: the benefits of utilization of the 340B program in a rural hospital outweigh the 
barriers. The secondary hypothesis was: that the 340B program increases access to medications to the uninsured 
population while maintaining profitability for rural hospitals and affiliated provider based clinics. 
The research methodology used for this study was a literature review complemented with a semi-structured 
interview with an expert in 340B program in a rural hospital in Huntington, West Virginia. Only pertinent answers to 
questions in Appendix A were included to provide a comprehensive overview in support of relevant academic journal 
articles. Search engines available through the Marshall University website were used to access the literature that was 
utilized. The key phrases “340B” AND “rural hospitals” or “critical access hospitals” AND “provider based clinics” 
OR “provider based facility” OR “FQHC” were used to search online databases for scholarly articles. Scholarly 
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databases consisted of PubMed, Medline, ProQuest, EBSCOHost, Science Direct, Academia Search Premier, and 
Google Scholar. Information from healthcare organizations and government websites, such as the Health Resources 
and Services Administration and Office of Pharmacy Affairs were reviewed.  Articles were limited to the English 
language and published 2004 through 2014 to obtain current information. Primary and secondary data were included 
from original articles, research studies and reviews. References cited by published sources were also reviewed for 
relevant articles. One hundred twenty two articles were reviewed and after review of abstracts was performed, 21 
articles were chosen for this research study. The search was completed by HA and LV and validated by AC who acted 
as a second reader and also double checked if references met the research study inclusion criteria.  
The conceptual framework for this research is illustrated in Figure 1. The research approach for the 
comparison of the benefits and the barriers to implementation of the 340B Program followed the systematic steps and 
conceptual framework utilized by Yao, Chu, & Li (2010). The framework emphasizes the need and demand impacting 
a hospital’s decision to implement the 340B program and the barriers encountered. The benefits and barriers vary 
according to the level examined: federal, state, local, and rural. Each level impacts the ultimate decision made 
regarding implementation of 340B program. (Figure 1) 
  FIGURE 1 
The findings are presented in the subsequent sections using categories of utilization under the headings: 
Collaboration of Cabell Huntington Hospital and Marshall Health, Benefits of 340B Program Utilization, and Barriers 
of 340B Program Utilization. 
RESULTS 
Collaboration of Cabell Huntington Hospital and Marshall Health 
Due to rapid changes in the healthcare arena, executives at Marshall Health, the practice arm of JCESOM, 
entered into an agreement with CHH to become provider based clinics and participants in the 340B program. This 
strategic move has allowed the academic health center to enhance its market share, stabilize the organization’s 
financial position by improving efficiency and quality measures by targeting the needs of its rural patient population. 
These bold moves have allowed Marshall Health to fulfill its mission of providing care to the vulnerable populations 
while maintaining fiscal responsibilities in a changing healthcare environment (Joe McGlothlin, personal 
communication, April 25, 2014). While CHH has been the entity obtaining the 340B status, administrators of CHH 
and Marshall Health, along with JCESOM and MU School of Pharmacy, have formed a partnership to manage an 
outpatient pharmacy, Marshall Pharmacy, separate from CHH inpatient pharmacy. Staff of the outpatient pharmacy 
are employed by Marshall Health and not CHH thereby reducing CHH pharmacy staffing costs. Currently, the 
outpatient portion of CHH pharmacy fills only prescriptions for CHH employees. Marshall Pharmacy will assume this 
duty also, allowing CHH pharmacy staff to focus on the needs of hospitalized patients. Medications to stock the 
outpatient pharmacy have been purchased at 340B prices. While employees of Marshall Health and CHH may utilize 
Marshall Pharmacy for prescription needs, only the employees who have been discharged from CHH or seen by a 
physician of Marshall Health, provider based clinics of CHH, are eligible to receive medications covered by the 340B 
program. All other customers will purchase prescriptions from medications not purchased under the program, similarly 
to patients with Medicaid coverage.  
The type and volume of care provided in rural areas has been expanded as a result of the 340B program 
leading to median savings of $10,000 per month in prescription purchases (Radford, Slifkin, Schur, Cheung, & 
Baernholdt, 2008). Savings has been greatest on cancer chemotherapy and adjunct medications bolstering the immune 
system secondary to adverse effects of chemotherapy (Warren & Shanker, 2013). Disbursement on clinic-administered 
prescriptions has been indicated to increase more rapidly than overall hospital disbursement, at annual rates of 12%-
14%. Increase in cost of outpatient clinic-administered medications has been linked to implementation of Medicare 
Part D, as well as newly developed drugs in specialized therapeutic areas (Hoffman, et al., 2008). 
As of January 2014, there were 24,769 registered sites utilizing 340B with 11,093 being hospitals and the 
rest being contract pharmacies (Apexus, 2014). In order to provide prescription service on an outpatient basis, the 
pharmacy dispensing medications under 340B federal program may be owned by the enrolled hospital or the pharmacy 
service can be contracted out to local retail pharmacies or mail order provider (Apexus, 2014). The majority of 
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hospitals utilized in-house pharmacies at 82% while contract pharmacies, either retail or mail order, comprise the other 
18% (HRSA, 2014). A third option of a combination of a hospital owned pharmacy working in conjunction with a 
contract pharmacy to provide medications to patients is being implemented at CHH and Marshall Health. Outpatient 
service covers prescriptions to be taken by the patient at home and also physician administered medication in clinic 
practice as part of an outpatient procedure, day surgery or outpatient chemotherapy (Joe McGlothlin, personal 
communication, April 25, 2014). Currently 340B drug purchases are greater than $6 billion per year. That is an 
increase from $1 billion per year just a decade ago, but pales in comparison to estimates of $12 billion by 2016 (Conti 
& Bach, 2013).           
Benefits of 340B Program Utilization   
By design, the 340B program has required drug manufacturers to offer substantial discounts on medications 
delivered in outpatient settings. The typical discount has been between 30% to 50%, leading to tremendous 
prescription cost savings for the covered rural hospital and its provider based clinics (Conti & Bach, 2013) (Table 1).  
According to the pharmacy directors of rural hospitals in 2006, the pharmacy savings have ranged from $600 
to $158,000 per month depending upon whether chemotherapy was available on an outpatient basis or not (Radford, 
et al., 2008) (Table 1). The 340B program does not prevent hospitals from billing patients or insurance providers the 
maximum allowable amount or to pass the acquisition cost savings along to consumers. As a result, the savings from 
participation in 340B program have been used to increase or improve services, offset losses from providing the 
pharmacy services or offset losses in other hospital departments, fund staff positions, and reduce patient prices for 
purchased prescriptions (Barlas, 2011) (Table 1). 
Barriers of 340B Program Utilization 
One of the most commonly documented barriers to implementation of 340B program has been the 
complexities affiliated with operating a pharmacy in compliance with additional federal statutes, regulations, and 
guidelines (Barlas, 2011). Transparent communication and work flow between administration, pharmacy, and 
Pharmacy Benefit Manager have been essential. Pharmacy logistics included, but were not limited to, understanding 
pharmacy reporting of cost analysis, management software system to track inventory, and implementation of a 
replenishment system for medications (Wilensky, 2010) (Table 2). 
 According to Health Resources and Services Administration, all new covered entities and their 
corresponding outpatient clinics must be registered three month prior to the effective start. The only exception to this 
rule is when a Public Health Emergency has been declared (Federal Register, 2012). For example, Marshall Pharmacy, 
providing outpatient prescription delivery under 340B contract beginning April 1, 2014, had to be registered between 
January 1- January 15, 2014 (Joe McGlothlin, personal communication, April 25, 2014).  
There are no specific directions as to how drug delivery under 340B should be implemented, however there 
is an expectation that all statutes, guidelines, and federal regulations will be adhered to so the entity will be in 
compliance (Federal Register, 2012). Due to enhanced Congressional oversight, governmental attention to the 340B 
program has increased. Communications between Republican Congressmen and the Pharmaceutical Manufacturers of 
America has alleged possible noncompliance. Complaints from the National Community Pharmacists Association has 
highlighted the need for further education explaining the 340B program and who is eligible to receive medications 
through the program (Mitka, 2012b). In addition, the PPACA has required recertification on an annual basis and has 
allowed for audits and penalties for institutions found not to be in compliance (Wallack, 2013) (Table 2). According 
to McGlothlin (2014), one of the greatest challenges regarding utilization of 340B has been implementing separate 
records for inpatient, outpatient, and specifically Medicaid medications. CHH is working with their IT departments to 
create separate virtual drug inventories rather than actual separate physical inventories. To further complicate the 
matter, hospital employees routinely have received reduced prescription costs as part of union negotiations (Joe 
McGlothlin, personal communication, April 25, 2014). Employees of the hospital and subsequent facility based clinics 
can only receive prescriptions obtained under the 340B program if their primary care has been provided by the covered 
entity. Employees who seek primary care elsewhere are entitled to prescription coverage cannot be provided with 
drugs purchased on 340B program (Phillipe, Andrus, Sims, & McDaniel, 2010). 
DISCUSSION 
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The purpose of this research was to examine the utilization of the 340B program at a rural hospital and its 
provider based clinics affiliated with a university medical school to assess the benefits and barriers to its 
implementation. Prior to 2003, few rural hospitals with less than 500 beds qualified for the 340B program. The 
Medicare Modernization Act corrected this by increasing the disproportionate share hospitals cap from 5.25% to 
11.75%. Patients who have been uninsured or underinsured have had limited access to expensive prescriptions which 
leads to noncompliance due to financial difficulties, hospital admissions due to lack of medications, and ultimately 
increased burden to the U.S. health care system. 
Benefits of 340B Program Utilization 
The finding of this study suggest that the Uutilization of the 340B program has increased access of affordable 
prescriptions to the uninsured population who are discharged patients of a rural hospital or its affiliated provider based 
clinics. The 340B program has required pharmaceutical manufacturers to provide outpatient medications at or below 
the 340B ceiling prices to enrollees. While acquisition costs have been reduced, reimbursement has not when 
prescriptions have been filled for patients who have been fully insured. 
A motivating factor to implement the 340B program has been to increase revenues of the rural hospital and 
its clinics in order to support other underfunded initiatives. According to McGlothlin (2014), Marshall Pharmacy will 
be owned by CHH, staffed by employees of Marshall Health, and will offer learning opportunities for students of both 
JCESOM and School of Pharmacy. Marshall Pharmacy has planned to implement a program called “Meds to Beds”. 
A pharmacist or pharmacy intern will deliver medications to the hospital room when patients have been scheduled for 
immediate discharge from CHH. In addition to alleviating the need for the patient to pick up prescriptions after leaving 
the hospital, the pharmacist or intern will provide counseling in a private setting allowing the patient adequate time to 
ask questions regarding prescription indications, directions, and potential side effects. Future plans include delivery 
of prescriptions to patients that are seen in Marshall Health provider based clinics of Internal Medicine, Family 
Practice, Psychiatry, Pediatrics, Orthopedic Surgery, General Surgery, Oral Surgery, and Obstetrics-Gynecology. 
Patients will have the opportunity to ask questions of both the pharmacist and their physicians prior to leaving the 
clinic. The additional revenue has helped compensate for the reduced reimbursements from state Medicaid agencies 
and the projected declining federal support beginning in 2014. 
In addition, the benefits of cost savings of $10,000 average per month and the additional revenue of $160,000 
to $200,000 per year of the 340B program in rural hospitals suggest that the benefits outweighs the barriers of 
maintaining separate drug inventories, additional pharmacy staff salaries, and audits. 
Barriers to 340B Utilization 
Not all eligible rural hospitals have participated in the 340B program due to HRSA regulations, reporting 
requirements, difficulty in obtaining complete information regarding implementation, costs of start- up inventory, 
increased pharmacy staffing, and lack of awareness of eligibility. Federal regulations and guidelines established in 
2010 by the PPACA have included annual recertification of all enrollees, audits, and penalties for noncompliance.  
One of the most daunting barriers to implementation of the 340B program has been the complexity associated 
with operating an outpatient pharmacy. The inventory may be used to fill prescriptions for patients discharged from 
the hospital or patients of the provider based clinics regardless of insurance status, excluding patients with Medicaid 
coverage. Medications used within the clinics to treat patients, including chemotherapy, have been covered under the 
340B program as well. Separate records for inpatient and outpatient medications have been necessary because 
inventory purchased under the 340B program cannot be used for inpatient purposes. Inventory does not need to be 
separated physically but can be separated virtually through management information systems. Inventory 
administration and tracking have required additional pharmacy staff.  
This research has focused on the utilization of 340B program in a disproportionate share hospital in a rural 
area. The limitations of this study did not examine the 340B program as it has been applied to critical access hospitals, 
cancer and children hospitals in urban areas. The ultimate success of the program at Cabell Huntington Hospital has 
been accomplished due to close partnership with Marshall Health and Marshall University, which may be difficult to 
replicate at larger institutions. Research bias cannot be excluded from this study. The search strategy also limited this 
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study due to the select few databases used for article selection. Publication bias may be also present. Most articles 
reviewed supported the utilization of 340B program.  
Practical Implications 
The 340B program has been a comprehensive plan to improve health outcomes in the population who are 
uninsured or underinsured in rural area. In addition, JCESOM and MU School of Pharmacy will utilized this program 
to educate their students. This model could be duplicated at other hospitals, both urban and rural, affiliated with 
medical schools to educate all students in healthcare, medical, pharmacy, and nursing, regarding collaboration for 
improving patient outcomes and reducing unnecessary hospitalizations within 30 days of discharge. 
Future research should focus on the impact of orphan drug exclusion on the utilization of 340B program. 
With Medicaid expansion, the consequences of using 340B drugs for Medicaid patients with subsequent cost savings 
being passed on to individual states should be examined. 
CONCLUSION 
TThe utilization of the 340B program might increases access to medications to the uninsured population 
while it may maintain ing profitability for rural hospitals and affiliated provider based clinics. In addition, the benefits 
of cost savings of $10,000 average per month and the additional revenue of $160,000 to $200,000 per year of the 340B 
program in rural hospitals outweighs the barriers of maintaining separate drug inventories, additional pharmacy staff 
salaries, and audits. 
a Personal Communication, J. McGlothlin, April 25, 2014 
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Promote Utilization 
 
 
 
  Impede Utilization 
Figure 1 Conceptual framework: Benefits and Barriers to 340B utilization 
Source: Yao, Chu, & Li, 2010.  
Table 1 : Benefits of Utilization of 340B Program 
Author & Year Benefits 
Radford, et al., 2008 Savings : $10,000 average per month 
$600-$158,000 per month depending upon practice 
Barlas, 2011 Additional revenue of $160,000- $200,00 per year 
permitted staff positions to be funded 
Hart & Siegel, 2012 Bill Medicaid & commercial insurers at standard rate of 
average wholesale price plus dispensing fee 
Conti & Bach, 2013 Prescription discounts 30%- 50% 
Table 2: Barriers of Utilization of 340B Program 
Author & Year Barriers 
Benefits 
Utilization of 340B in 
Rural Hospital 
Need for Affordable 
Prescription Prices 
Expensive 
Prescription 
Prices   Barriers
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 Young, 2006 Lack of pricing transparency from pharmaceutical 
manufacturers 
Wilensky, 2010 Pharmacy tracking to prevent diversion and duplicate 
discount due to mixed use inventory 
Wallack, 2013 Certification of 340B entity on annual basis Audits & 
penalties for noncompliance 
APPENDIX A 
Semi-structured interview of Joe McGlothlin, RPh, Director of Marshall Pharmacy, Outpatient Pharmacy of Cabell 
Huntington Hospital: 
 How have you implemented the 340B program into your practice in your healthcare entity?
 What method do you use to provide 340B program to your patients in an outpatient/inpatient setting?
 How is responsibility delegated to who is involved in 340B implementation in your facility? 
 What services are provided via 340B? 
 How have patients reacted to the utilization of 340B?
 How has 340B benefitted your practice?
 How has the utilization of 340B affected patient access to medications? 
 How has the utilization of 340B affected the cost of providing prescriptions to patients in your practice? 
 Are there any other significant benefits or barriers to 340B utilization in your practice that we have not
discussed? 
